Brickell Biotech Interest Expense 2011-2026 | BBI

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Brickell Biotech

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
5 K	9 K	69 K	-	2.1 M	1.09 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.1 M	5 K	654 K

Quarterly Interest Expense Brickell Biotech

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	2 K	3 K	-	-	2 K	4 K	-	1 K	30 K	34 K	-	-	-	-	-	1.1 M	660 K	224 K	-	267 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.1 M	1 K	211 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
AbCellera Biologics ABCL	-2.71 M	$ 3.66	1.25 %	$ 1.09 B	Canada
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Black Diamond Therapeutics BDTX	6.92 M	$ 2.4	-3.04 %	$ 132 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Alector ALEC	13.2 M	$ 2.12	-12.96 %	$ 218 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA
Altimmune ALT	48 K	$ 4.22	-2.09 %	$ 300 M	USA
Arena Pharmaceuticals ARNA	4.16 M	-	-6.81 %	$ 3.04 B	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	103 K	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	3.02 M	-	-16.42 %	$ 249 M	USA
AVEO Pharmaceuticals AVEO	1.6 M	-	-	$ 521 M	USA
Atreca BCEL	3 K	-	-11.76 %	$ 5.79 M	USA
Apellis Pharmaceuticals APLS	-133 K	$ 20.76	-0.95 %	$ 2.62 B	USA
Agenus AGEN	1.26 M	$ 3.35	0.45 %	$ 1.2 M	USA
Agios Pharmaceuticals AGIO	1.96 M	$ 28.99	-4.1 %	$ 1.68 B	USA
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA